X

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
3 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
2.6 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
FRPT icon
976
Freshpet
FRPT
$3.27B
$395K ﹤0.01%
3,051
+418
+16% +$50.2K
2023 Q4
2 quarters
DOCS icon
977
Doximity
DOCS
$5.33B
$392K ﹤0.01%
14,025
-4,410
-24% -$116K
2022 Q2
8 quarters
MSM icon
978
MSC Industrial Direct
MSM
$7.4B
$391K ﹤0.01%
4,935
-548
-10% -$48.7K
2020 Q2
16 quarters
ROIV icon
979
Roivant Sciences
ROIV
$24.3B
$391K ﹤0.01%
36,972
-34,328
-48% -$376K
2023 Q2
4 quarters
HGV icon
980
Hilton Grand Vacations
HGV
$2.7B
$388K ﹤0.01%
9,599
-1,118
-10% -$47.5K
2023 Q1
5 quarters
CC icon
981
Chemours
CC
$1.93B
$387K ﹤0.01%
17,144
-645
-4% -$16.9K
2020 Q2
16 quarters
TCBI icon
982
Texas Capital Bancshares
TCBI
$3.85B
$386K ﹤0.01%
6,313
-507
-7% -$29.9K
2020 Q2
16 quarters
KMPR icon
983
Kemper
KMPR
$1.63B
$386K ﹤0.01%
6,501
-702
-10% -$41.2K
2020 Q2
16 quarters
AMED icon
984
DELISTED
Amedisys
AMED
$381K ﹤0.01%
4,152
-988
-19% -$91.7K
2020 Q2
16 quarters
VSH icon
985
Vishay Intertechnology
VSH
$4.43B
$381K ﹤0.01%
17,082
-1,141
-6% -$25.8K
2020 Q2
16 quarters
NVO icon
986
Novo Nordisk
NVO
$168B
$380K ﹤0.01%
2,665
+576
+28% +$76.3K
2023 Q3
3 quarters
NEU icon
987
NewMarket
NEU
$8.19B
$379K ﹤0.01%
736
-61
-8% -$33.9K
2020 Q2
16 quarters
CDP icon
988
COPT Defense Properties
CDP
$3.77B
$379K ﹤0.01%
15,155
-1,012
-6% -$24.3K
2020 Q2
16 quarters
EPR icon
989
EPR Properties
EPR
$4.18B
$376K ﹤0.01%
8,963
-1,537
-15% -$63.2K
2020 Q2
16 quarters
BCC icon
990
Boise Cascade
BCC
$2.58B
$375K ﹤0.01%
3,146
-41
-1% -$5.57K
2023 Q2
4 quarters
RVMD icon
991
Revolution Medicines
RVMD
$41.5B
$375K ﹤0.01%
9,651
+1,175
+14% +$43.9K
2023 Q4
2 quarters
AX icon
992
Axos Financial
AX
$4.91B
$373K ﹤0.01%
6,523
+1,103
+20% +$60K
2023 Q4
2 quarters
SITE icon
993
SiteOne Landscape Supply
SITE
$3.9B
$373K ﹤0.01%
3,069
+214
+7% +$32.4K
2021 Q2
12 quarters
IRDM icon
994
Iridium Communications
IRDM
$4.85B
$372K ﹤0.01%
13,968
-11,046
-44% -$311K
2021 Q1
13 quarters
SLGN icon
995
Silgan Holdings
SLGN
$3.78B
$372K ﹤0.01%
8,779
-940
-10% -$43.7K
2020 Q2
16 quarters
BFAM icon
996
Bright Horizons
BFAM
$3.33B
$371K ﹤0.01%
3,372
-453
-12% -$49K
2022 Q4
6 quarters
RHP icon
997
Ryman Hospitality Properties
RHP
$8.47B
$371K ﹤0.01%
3,714
+162
+5% +$17.1K
2021 Q2
12 quarters
MTH icon
998
Meritage Homes
MTH
$3.78B
$370K ﹤0.01%
4,576
+128
+3% +$10.8K
2023 Q1
5 quarters
LITE icon
999
Lumentum
LITE
$81.2B
$369K ﹤0.01%
7,252
-762
-10% -$34.5K
2020 Q2
16 quarters
GKOS icon
1000
Glaukos
GKOS
$9.9B
$369K ﹤0.01%
3,118
+241
+8% +$25.6K
2023 Q3
3 quarters
38 39
40
41 42

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.